Clinical Trials · NCT03885297
3mg Liraglutide for Overweight or Obesity
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
- Enrollment
- 43
- Start date
- Jan 2019
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Weight changes related to treatment